Abimono 600 mg - fungal and bacterial infections - 1 vaginal ovule

Product Description

1 Vaginal Ovule

Composition:

ABIMONO vaginal ovule One ovule contains Active ingredient: Isoconazole nitrate 0.6 g Excipients: Boric acid 0.3 g Semi-synthetic glycerides 2.4 gABIMONO gynecological cream 1% 100 g of cream contain: Active ingredient: Isoconazole nitrate 1.00 g Excipients: Sorbitan monostearate 1.00 g Polyoxyethylene sorbitan monostearate g 3.50 g Cetylstearyl alcohol 5.00 g White petrolatum 10.00 g Isopropyl myristate 10.00 g Distilled water 69.50 g ABIMONO dermatological cream 1% 100 g of cream contain: Active ingredient: Isoconazole nitrate 1.00 g Excipients: Polysorbate 60 3.50 g Sorbitan monostearate 1.00 g Cetearyl alcohol 5.00 g Liquid paraffin 10.00 g White petrolatum 10.00 g Distilled water to 100 g

Excipients
Therapeutic indications

Vaginal ovule – Cream: Vulvo-vaginal fungal infections also with bacterial superinfection. Dermatological cream: Superficial mycoses of glabrous or hairy skin (dermatophytia, candidiasis, pityriasis versicolor).

Contraindications

Known or suspected hypersensitivity to the components of the medicinal product and to other antifungal imidazole derivatives.

Dosage

Vaginal ovule: Insert one 600 mg ovule deeply into the vagina. The possibility of treatment exceeding the first day must be evaluated by the attending physician. Gynecological cream: one application per day for one week, unless otherwise prescribed by the doctor. To use, screw the applicator onto the tube, fill it completely with cream, then insert it into the vagina and empty it by pressing the plunger. After each introduction, disassemble the applicator and dispose of it in the appropriate waste. Treatment with ABIMONO should not be performed during menstruation. It is recommended that your partner use ABIMONO dermatological cream at the same time. Dermatological cream: Unless otherwise prescribed by your doctor, the dosage is 2 applications per day.

Warnings and precautions

Vaginal ovule–Cream: During treatment and in the days immediately following, to avoid reinfection, it is necessary to change towels and underwear daily and sterilize them by boiling. Dermatological cream: To ensure the success of the treatment, it is necessary to scrupulously observe hygiene precautions, including carefully drying the spaces between the toes in the case of localized foot mycosis. Local treatment for fungal infections generally lasts 2–3 weeks, and sometimes up to 4 weeks in stubborn cases (especially in the spaces between the toes). Longer treatments are also possible upon specific medical prescription. In case of lesions, it is often advisable to insert a compress soaked in cream between the toes. If applied to the face, avoid contact of ABIMONO with the eyes. Use of topical products, especially if prolonged, may give rise to sensitization phenomena. In this case, treatment must be discontinued and appropriate therapy initiated. The same applies in the event of the development of microorganisms. KEEP THE MEDICINE OUT OF THE REACH AND SIGHT OF CHILDREN.

Interactions

No negative interactions with other drugs have been reported.

Side effects

Vaginal Ovule–Cream: Vaginal burning and irritation, pelvic cramps, skin rashes and headache have been reported with medications of this type. In these cases, treatment must be discontinued and appropriate therapy initiated. The same procedure should be followed in the case of non-sensitive microorganisms. Dermatological cream: Skin irritation phenomena of very rare occurrence.

Pregnancy and breastfeeding

In pregnant women, the product should be administered only in cases of real need, under the direct supervision of a doctor.